TY - JOUR
T1 - Analysis of the Change in Sleep Quality in Lung Transplant Recipients
AU - Tokuno, J.
AU - Oga, T.
AU - Chen-Yoshikawa, T. F.
AU - Oto, T.
AU - Okawa, T.
AU - Okada, Y.
AU - Akiba, M.
AU - Ikeda, M.
AU - Tanaka, S.
AU - Yamada, Y.
AU - Yutaka, Y.
AU - Ohsumi, A.
AU - Nakajima, D.
AU - Hamaji, M.
AU - Isomi, M.
AU - Chin, K.
AU - Date, H.
N1 - Publisher Copyright:
Copyright © 2020. Published by Elsevier Inc.
Copyright:
This record is sourced from MEDLINE/PubMed, a database of the U.S. National Library of Medicine
PY - 2020/4/1
Y1 - 2020/4/1
N2 - PURPOSE: We previously reported that sleep quality is impaired in waitlisted patients for lung transplantation in Japan, and that respiratory symptoms and psychological status were main contributive factors to sleep quality. However, it is unknown whether sleep quality would improve after lung transplantation or not. Then we aim to assess changes in sleep quality and other patient reported measures including health related quality of life (HRQL) after lung transplantation. METHODS: In this multicentric study, we prospectively collected patient-reported data of 56 lung transplant recipients. We assessed sleep quality using the Pittsburgh Sleep Quality Index (PSQI), HRQL using the St. George's Respiratory Questionnaire (SGRQ), psychological status using Hospital Anxiety and Depression Scale (HADS) and dyspnea using modified Medical Research Council Dyspnea Scale (mMRC). We then examined the changes in sleep quality, HRQL, psychological status and dyspnea within about one year after lung transplantation. We also assessed PSQI subscale scores to examine the details of changes in sleep quality. RESULTS: Interstitial pneumonia (n=24), pulmonary complication after post hematopoietic stem cell transplantation (n=8), chronic obstructive pulmonary disease (n=7) and lymphangioleiomyomatosis (n=7) were the four most frequent indications. HRQL, psychological status and dyspnea significantly improved after lung transplantation (p< 0.0001). The PSQI score neither significantly change from 6.7 ± 3.6 to 7.1 ± 3.8 (p = 0.38), nor the percentage of the patients with poor sleep quality (PSQI > 5) changed significantly from 51.7% (at baseline) to 62.5% (after lung transplantation) (p = 0.25). In PSQI subscales, sleep medication worsened significantly (p= 0.04) after lung transplantation. CONCLUSION: While lung transplantation had positive impacts on HRQL, psychological status and dyspnea, sleep quality remained unchanged. Sleep quality should be followed separately from those patient-reported measures not to miss its worsening.
AB - PURPOSE: We previously reported that sleep quality is impaired in waitlisted patients for lung transplantation in Japan, and that respiratory symptoms and psychological status were main contributive factors to sleep quality. However, it is unknown whether sleep quality would improve after lung transplantation or not. Then we aim to assess changes in sleep quality and other patient reported measures including health related quality of life (HRQL) after lung transplantation. METHODS: In this multicentric study, we prospectively collected patient-reported data of 56 lung transplant recipients. We assessed sleep quality using the Pittsburgh Sleep Quality Index (PSQI), HRQL using the St. George's Respiratory Questionnaire (SGRQ), psychological status using Hospital Anxiety and Depression Scale (HADS) and dyspnea using modified Medical Research Council Dyspnea Scale (mMRC). We then examined the changes in sleep quality, HRQL, psychological status and dyspnea within about one year after lung transplantation. We also assessed PSQI subscale scores to examine the details of changes in sleep quality. RESULTS: Interstitial pneumonia (n=24), pulmonary complication after post hematopoietic stem cell transplantation (n=8), chronic obstructive pulmonary disease (n=7) and lymphangioleiomyomatosis (n=7) were the four most frequent indications. HRQL, psychological status and dyspnea significantly improved after lung transplantation (p< 0.0001). The PSQI score neither significantly change from 6.7 ± 3.6 to 7.1 ± 3.8 (p = 0.38), nor the percentage of the patients with poor sleep quality (PSQI > 5) changed significantly from 51.7% (at baseline) to 62.5% (after lung transplantation) (p = 0.25). In PSQI subscales, sleep medication worsened significantly (p= 0.04) after lung transplantation. CONCLUSION: While lung transplantation had positive impacts on HRQL, psychological status and dyspnea, sleep quality remained unchanged. Sleep quality should be followed separately from those patient-reported measures not to miss its worsening.
UR - http://www.scopus.com/inward/record.url?scp=85085636000&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85085636000&partnerID=8YFLogxK
U2 - 10.1016/j.healun.2020.01.515
DO - 10.1016/j.healun.2020.01.515
M3 - Article
C2 - 32465605
AN - SCOPUS:85085636000
SN - 1053-2498
VL - 39
SP - S391
JO - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
JF - The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation
IS - 4
ER -